Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,571 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases.
Deng YQ, Zhao H, Ma AL, Zhou JY, Xie SB, Zhang XQ, Zhang DZ, Xie Q, Zhang G, Shang J, Cheng J, Zhao WF, Zou ZQ, Zhang MX, Wang GQ; China HepB Related Fibrosis Assessment Research Group. Deng YQ, et al. Medicine (Baltimore). 2015 Nov;94(45):e2003. doi: 10.1097/MD.0000000000002003. Medicine (Baltimore). 2015. PMID: 26559292 Free PMC article.
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study.
Wu X, Shi Y, Zhou J, Sun Y, Piao H, Jiang W, Ma A, Chen Y, Xu M, Xie W, Cheng J, Xie S, Shang J, Cheng J, Xie Q, Ding H, Zhang X, Bai L, Zhang M, Wang B, Chen S, Ma H, Ou X, Jia J, You H. Wu X, et al. Among authors: ma a, ma h. Expert Opin Biol Ther. 2018 Jul;18(sup1):61-69. doi: 10.1080/14712598.2018.1451511. Expert Opin Biol Ther. 2018. PMID: 30063860 Clinical Trial.
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study.
Wu X, Zhou J, Xie W, Ding H, Ou X, Chen G, Ma A, Xu X, Ma H, Xu Y, Liu X, Meng T, Wang L, Sun Y, Wang B, Kong Y, Ma H, You H, Jia J. Wu X, et al. Among authors: ma a, ma h. Infect Drug Resist. 2019 Apr 1;12:745-757. doi: 10.2147/IDR.S185120. eCollection 2019. Infect Drug Resist. 2019. PMID: 31015765 Free PMC article.
[Combined anluohuaxianwan and entecavir treatment significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection].
Miao L, Yang WN, Dong XQ, Zhang ZQ, Xie SB, Zhang DZ, Zhang XQ, Cheng J, Zhang G, Zhao WF, Xie Q, Liu YX, Ma AL, Li J, Shang J, Bai L, Cao LH, Zou ZQ, Li JB, Lyu FD, Liu H, Wang ZJ, Zhang MX, Chen LM, Liang WF, Gao H, Zhuang H, Zhao H, Wang GQ. Miao L, et al. Among authors: ma al. Zhonghua Gan Zang Bing Za Zhi. 2019 Jul 20;27(7):521-526. doi: 10.3760/cma.j.issn.1007-3418.2019.07.009. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31357778 Clinical Trial. Chinese.
Unsatisfying antiviral therapeutic effect in patients with mother-to-child transmissed chronic hepatitis B virus infection: a prospective multi-center clinical study.
Li J, Dong XQ, Wu Z, Ma AL, Xie SB, Zhang XQ, Zhang ZQ, Zhang DZ, Zhao WF, Zhang G, Cheng J, Xie Q, Li J, Zou ZQ, Liu YX, Wang GQ, Zhao H; China Hepatitis B Related Fibrosis Assessment Research Group. Li J, et al. Chin Med J (Engl). 2019 Nov 20;132(22):2647-2656. doi: 10.1097/CM9.0000000000000522. Chin Med J (Engl). 2019. PMID: 31725459 Free PMC article.
Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT.
Wu Z, Ma AL, Xie Q, Zhang XQ, Cheng J, Zhang DZ, Wang GQ, Zhao H. Wu Z, et al. Clin Res Hepatol Gastroenterol. 2021 Mar;45(2):101463. doi: 10.1016/j.clinre.2020.05.011. Epub 2020 Jun 19. Clin Res Hepatol Gastroenterol. 2021. PMID: 32571749 Free article.
2,571 results